235 related articles for article (PubMed ID: 1533387)
1. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
Takashima H; Araki K; Miyazaki J; Yamamura K; Kimoto M
Immunology; 1992 Mar; 75(3):398-405. PubMed ID: 1533387
[TBL] [Abstract][Full Text] [Related]
2. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice.
Milich DR; Jones JE; Hughes JL; Maruyama T; Price J; Melhado I; Jirik F
J Immunol; 1994 Jan; 152(2):455-66. PubMed ID: 8283030
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.
Ferrari C; Penna A; Giuberti T; Tong MJ; Ribera E; Fiaccadori F; Chisari FV
J Immunol; 1987 Sep; 139(6):2050-8. PubMed ID: 2957446
[TBL] [Abstract][Full Text] [Related]
4. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
5. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
[TBL] [Abstract][Full Text] [Related]
6. H-2(d) mice born to and reared by HBeAg-transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products.
Merkle H; Deutschle T; Gastrock-Balitsch I; Nusser P; Knehr S; Reifenberg K
Virology; 2000 Jul; 273(1):149-59. PubMed ID: 10891417
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunogenicity of hepatitis B virus core and E antigens.
Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
[TBL] [Abstract][Full Text] [Related]
8. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.
Tsai SL; Chen PJ; Lai MY; Yang PM; Sung JL; Huang JH; Hwang LH; Chang TH; Chen DS
J Clin Invest; 1992 Jan; 89(1):87-96. PubMed ID: 1729285
[TBL] [Abstract][Full Text] [Related]
11. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence.
Milich DR; Chen MK; Hughes JL; Jones JE
J Immunol; 1998 Feb; 160(4):2013-21. PubMed ID: 9469465
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
13. Immune tolerance split between hepatitis B virus precore and core proteins.
Chen M; Sällberg M; Hughes J; Jones J; Guidotti LG; Chisari FV; Billaud JN; Milich DR
J Virol; 2005 Mar; 79(5):3016-27. PubMed ID: 15709022
[TBL] [Abstract][Full Text] [Related]
14. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.
Milich DR; McLachlan A; Moriarty A; Thornton GB
J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947
[TBL] [Abstract][Full Text] [Related]
15. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines.
Ferrari C; Mondelli MU; Penna A; Fiaccadori F; Chisari FV
J Immunol; 1987 Jul; 139(2):539-44. PubMed ID: 2439590
[TBL] [Abstract][Full Text] [Related]
17. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
19. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
20. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
